Browsing Centre for Haemato-Oncology by Title
Now showing items 215-217 of 217
-
Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML.
(2023-12-01)Molecular failure in NPM1 mutated AML inevitably progresses to frank relapse if untreated. Recently published small case series show that venetoclax combined with low dose cytarabine or azacitidine can reduce or eliminate ...